Skip Navigation

COVID-19 Update

Find a Doctor

Find a Researcher


Jonathan Allen Webster, M.D.

Photo of Dr. Jonathan Allen Webster, M.D.
  • Assistant Professor of Oncology

Specializes in: Adults (18+ years)



Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), Internal Medicine, Oncology

Research Interests

Immunotherapy; Acute Leukemias

Request an Appointment

Insurance Information



Outside of Maryland

Request Appointment

International Patients

Request Appointment


Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Appointment Phone: 410-955-8893
401 N. Broadway
Baltimore, MD 21231 map
Fax: 410-614-7279


Dr. Webster attended medical school at Stanford University followed by residency and fellowship training at Johns Hopkins Hospital. He is a medical oncologist specializing in adult leukemia. He primarily sees patients with acute lymphoblastic leukemia, chronic myeloid leukemia, and acute myeloid leukemia. His research focuses on the treatment of acute lymphoblastic leukemia including the incorporation of novel therapies as well the treatment and prevention of central nervous system leukemia. He is also actively involved in developing trials incorporating immunotherapy into the treatment of leukemia and developing new strategies to prevent leukemia relapse following allogeneic hematopoietic stem cell transplant. more


  • Assistant Professor of Oncology

Departments / Divisions



  • MD, Stanford University School of Medicine (2011)


  • Johns Hopkins University School of Medicine / Internal Medicine (2014)


  • Johns Hopkins University School of Medicine / Medical Oncology (2017)

Board Certifications

  • American Board of Internal Medicine / Internal Medicine (2014)
  • American Board of Internal Medicine / Medical Oncology (2016)

Research & Publications

Clinical Trial Keywords

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia

Selected Publications

View all on Pubmed

Webster JA, Tibes R, Morris L, Blackford AL, Litzow M, Patnaik M, Rosner GL, Gojo I, Kinders R, Wang L, Doyle LA, Huntoon CJ, Karnitz LM, Kaufmann SH, Karp JE, Smith BD. Randomized phase II trial of cytosine arabinoside with and without the CHK1 inhibitor MK-8776 in relapsed and refractory acute myeloid leukemia. Leuk Res. 2017;61:108-116

Webster JA, Pratz KW. Acute myeloid leukemia in the elderly: therapeutic options and choice. Leuk Lymphoma. 2018 Feb; 59(2): 274

Webster J, Smith BD The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia. Clin Ther. 2019 Feb;41(2):336-349. doi: 10.1016/j.clinthera.2018.12.013. Epub 2019 Jan 30

Sterling C1, Webster J Harnessing the immune system after allogeneic stem cell transplant in acute myeloid leukemia. Am J Hematol. 2020 May;95(5):529-547. doi: 10.1002/ajh.25750. Epub 2020 Feb 19

Contact for Research Inquiries

1650 Orleans St., CRB1 Room 245
Baltimore, MD 21287 map
Phone: 410-614-9106

Activities & Honors


  • American Society of Hematology, 2015
  • American Society of Clinical Oncology, 2014

Patient Ratings & Comments

The Patient Rating score is an average of all responses to physician related questions on the national CG-CAHPS Medical Practice patient experience survey through Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments are also gathered from our CG-CAHPS Medical Practice Survey through Press Ganey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

  • ...Loading ratings...
  • ... 
  • ... 
  • ... 
  • ... 
  • ... 


Is this you? Edit Profile
back to top button